P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders.

Chen Y, Du X, Li F, Yuan S, Wang W, Zhu Z, Wang M, Gu C.

Open source

DOI
10.1002/cns.71139
Published
2026-09-01
Container
CNS Neurosci Ther
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cns.71139,
  title = {P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders.},
  author = {Chen Y and  Du X and  Li F and  Yuan S and  Wang W and  Zhu Z and  Wang M and  Gu C.},
  year = {2026},
  journal = {CNS Neurosci Ther},
  doi = {10.1002/cns.71139},
  url = {https://doi.org/10.1002/cns.71139}
}

RIS

TY  - JOUR
TI  - P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders.
AU  - Chen Y
AU  -  Du X
AU  -  Li F
AU  -  Yuan S
AU  -  Wang W
AU  -  Zhu Z
AU  -  Wang M
AU  -  Gu C.
PY  - 2026
JO  - CNS Neurosci Ther
DO  - 10.1002/cns.71139
UR  - https://doi.org/10.1002/cns.71139
ER  - 

APA

Y, C., X, D., F, L., S, Y., W, W., Z, Z., M, W., & C., G. (2026). P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders.. CNS Neurosci Ther. https://doi.org/10.1002/cns.71139

Source records